US Patent 10131702 Glucagon-GLP-1-GIP triple agonist compounds
Patent 10131702 was granted and assigned to Zealand Pharma A/S on November, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+185 characters)
Article
Patent abstract
The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Anne Pernille Tofteng Shelton0
Ditte Riber0
Kate Hansen0
Lene Jessen0
Rasmus Just0
Torben Østerlund0
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101317020
Date of Patent
November 20, 2018
0Patent Application Number
150347840
Date Filed
November 6, 2014
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 23 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10131702 Glucagon-GLP-1-GIP triple agonist compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10131702
Date of patent
November 20, 2018
Patent application number
15034784
Date Filed
November 6, 2014
Patent primary examiner
Find more entities like US Patent 10131702 Glucagon-GLP-1-GIP triple agonist compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
